Psychometric Properties of The Drug Abuse Screening Test (DAST-10) in Heroin Dependent Adults and Adolescents with Drug Use Disorder

Amaç: Bu çalışmanın amacı, madde sorunu yaşayan bireyleri tarama amaçlı geliştirilen Madde Kötüye Kullanımı Tarama Testi'nin (DAST-10) psikometrik özelliklerinin madde kullanım bozukluğu olan Türk hastalarda değerlendirilmesidir. Yöntem: Çalışmaya, ergenler için madde kötüye kullanımı tedavi programında olan ve madde kullanım bozukluğu bulunan 100 ergen, madde kötüye kullanımı yatılı tedavi programındaki 123 erişkin eroin bağımlısı hasta ve aynı klinikten alkol bağımlılığı olan ve madde kötüye kullanımı sorunu iletmeyen 35 hasta katıldı. Bulgular: DAST-10'un DUDIT (Madde Kullanım Bozukluğu Tanıma Testi) ile ilişkisine bakıldığında, yüksek konverjan geçerlik (r=0.76) gösteren ve Cronbach alfa değeri 0.92 olan, psikometrik olarak güvenilir bir madde kötüye kullanımı tarama ölçeği olduğu bulunmuştur. Ek olarak, tek bileşen toplam varyansın %59.35'ini açıklamıştır. Kesme noktası 4 ve üzeri olarak alındığında DAST-10 duyarlılık ve özgüllük puanları, sırasıyla 0.98 ve 0.91 olarak bulunmuştur. Ayrıca DAST-10, alkol kullanım bozukluğu olan hastaları madde kullanım bozukluğu olan hastalardan anlamlı düzeyde ayırd ettiği için iyi düzeyde ayırıcı geçerlilik göstermiştir. Sonuç: Bu bulgular, DAST-10'un madde kullanım bozukluğu olan Türk hastalarda tek boyutlu yapıda ölçüm yapan geçerli ve güvenilir bir madde kötüye kullanımı tarama ölçeği olduğunu desteklemektedir. Ek klinik popülasyonlarda ve cezaevi ortamlarındaki gibi yüksek riskli popülasyonlarda daha ileri çalışmaların yapılması gerekmektedir

Madde Kötüye Kullanımı Tarama Testi’nin (DAST-10) eroin bağımlısı erişkinlerde ve madde kullanım bozukluğu olan ergenlerde psikometrik özellikleri

Objective: The psychometric properties of the Drug Abuse Screening Test (DAST-10), developed to screen individuals for drug problems, are evaluated in Turkish patients with drug use disorder. Method: Participants included 100 adolescents with drug use disorder in a substance abuse treatment program for adolescents, 123 heroin dependent adults in a residential substance abuse treatment program, and 35 alcohol dependents from the same clinic who did not report a drug abuse problem. Results: The DAST-10 was found to be a psychometrically sound drug abuse screening measure with high convergent validity (r=0.76) when correlation with the Drug Use Disorders Identification Test (DUDIT) was measured and to have a Cronbach’s alpha of 0.92. In addition, a single component accounted for 59.35% of total variance, and the DAST-10 had sensitivity and specificity scores of 0.98 and 0.91, respectively, when using the optimal cut-off score of 4. Additionally, the DAST-10 showed good discriminant validity as it significantly differentiated patients with drug use disorder from alcohol dependents. Conclusions: These findings support the DAST as a reliable and valid drug abuse screening instrument that measures a unidimensional construct. Further research is warranted with additional clinical populations and with high risk populations such as those in criminal justice settings

___

  • 1. Mdege ND, Lang J. Screening instruments for detecting illicit drug use/abuse that could be useful in general hospital wards: a systematic review. Addict Behav 2011; 36:1111-1119.
  • 2. Skinner H. The Drug Abuse Screening Test. Addict Behav 1982; 7:363-371.
  • 3. Gibbs LE. Validity and reliability of the Michigan Alcoholism Screening Test: a review. Drug Alcohol Depend 1985; 12:279- 285.
  • 4. Gavin DR, Ross HE, Skinner HA. Diagnostic validity of the Drug Abuse Screening Test in the assessment of the DSM III drug disorders. Br J Addict 1989; 84:301-307.
  • 5. Skinner HA, Goldberg AE. Evidence for a drug dependence syndrome among narcotic users. Br J Addict 1986; 81:471-484.
  • 6. Yudko E, Lozhkina O, Fouts A. A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. J Subst Abuse Treat 2007;32:189-198.
  • 7. Cocco KM, Carey KB. Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients. Psychol Assess 1998; 10:408-414.
  • 8. Bedregal LE, Sobell LC, Sobell MB, Simco E. Psychometric characteristics of a Spanish version of the DAST-10 and the RAGS. Addict Behav 2006; 31:309-319.
  • 9. Carey KB, Carey MP, Chandram PS. Psychometric evaluation of the alcohol use disorders identification test and short drug abuse screening test with psychiatric patients in India. J Clin Psychiatry 2003; 64:767-774.
  • 10. Voluse AC, Gioia CJ, Sobell LC, Dum M, Sobell MB, Simco ER. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment. Addict Behav 2012; 37:36-41.
  • 11. Maisto SA, Carey MP, Carey KB, Gordon CM, Gleason JR. Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess 2000; 12:186-192.
  • 12. McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients: the Addiction Severity Index. J Nerv Ment Dis 1980; 168:26-33.
  • 13. Brown R, Rounds L. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J 1995; 94:135-140.
  • 14. McCabe SE, Boyd CJ, Cranford JA, Morales M, Slayden J. A modified version of the Drug Abuse Screening Test among undergraduate students. J Subst Abuse Treat 2006; 31:297-303.
  • 15. Kaloyanides KB, McCabe SE, Cranford JA, Teter CJ. Prevalence of illicit use and abuse of prescription stimulants, alcohol, and other drugs among college students: relationship with age at initiation of prescription stimulants. Pharmacotherapy 2007; 27:666-674.
  • 16. Coskunol H, Bagdiken I, Sorias S, Saygili R. Validity and reliability of the Michigan Alcoholism Screening Test (Turkish version). Ege Tip Dergisi 1995; 34:15-18. (Turkish)
  • 17. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Washington D.C. and London. American Psychiatric Press, Inc, 1997.
  • 18. Corapcioglu A, Aydemir O, Yildiz M, Esen A, Koroglu E. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I), Clinical Version. Hekimler Yayin Birligi, Ankara, 1999. (Turkish)
  • 19. Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993; 88:791-804.
  • 20. Berman A, Bergman H, Palmstierna T, Schlyter F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 2005; 11:22-31.
  • 21. Evren C, Ovali E, Karabulut V, Cetingok S, Mutlu E. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with heroin dependent adults and adolescents with drug use disorder. Bulletin of Clinical Psychopharmacology 2014 (In Press).
  • 22. Byrne BM. Structural Equation Modeling with AMOS: Basic Concepts, Applications and Programming. Second Ed. New York: Taylor & Francis, 2010.
  • 23. Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate Data Analysis. Seventh Ed. New Jersey: Prentice-Hall, 2010.
  • 24. Mook J, Kleijn WC, van der Ploeg HM. Symptom-positively and negatively worded items in two popular self-report inventories of anxiety and depression. Psychol Rep 1991; 69:551-560.
Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi-Cover
  • ISSN: 1018-8681
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 1984
  • Yayıncı: Kare Yayıncılık
Sayıdaki Diğer Makaleler

A Possible Cause of Secondary Traumas for Children in Justice System of Turkey: Attitudes of Prosecutors and Judges

ONUR BURAK DURSUN, İbrahim Selçuk ESİN, Mustafa GÜLEÇ, MUSTAFA TALİP ŞENER, Fatma Varol TAŞ, Nazım Ercüment BEYHUN, MEHMET GÖDEKLİ

Post-Traumatic Stress Disorder and Anger in Migraine Patients

Süreyya KARŞIKAYA, Önder KAVAKÇI, Nesim KUĞU, AYŞEGÜL SELCEN GÜLER

Comparison of First Episode and Recurrent Major Depression Patients in Terms of Cognitive Function

Cigdem Ciftci KAYGUSUZ, Özden ARISOY, M Hamid BOZTAS, Mustafa SERCAN

Overview of The Psychiatric Reflections of Mobbing: Two Case Reports

Elif KARAAHMET

Evaluation of Suicide Attempts that Referred to a University Hospital Emergency Department

MEHMET ASOĞLU, Abdurrahman ALTINDAĞ, FERİDUN BÜLBÜL

A Rarely Diagnosed Sleep Disorder: Narcolepsy

Pınar Güzel ÖZDEMİR, Yavuz SELVİ

Psychometric Properties of The Drug Abuse Screening Test (DAST-10) in Heroin Dependent Adults and Adolescents with Drug Use Disorder

Cüneyt EVREN, FATMA YEŞİM CAN, Alkin YILMAZ, Ethem OVALI, Sera CETİNGOK, Vahapt KARABULUT, ELİF MUTLU

The Correlation of Suicide Attempt and Suicidal Ideation with Insight, Depression and Severity of Illness in Schizophrenic Patients

Gökhan UMUT, Zeren Ozturk ALTUN, Birim S. DANIŞMANT, İlker KÜÇÜKPARLAK, Nesrin KARAMUSTAFALIOĞLU, Mehmet Cem İLNEM

Seventy-two Months Ongoing Nephrogenic Diabetes Insipidus after Discontinuation of Lithium: A Case Report

GÜLÇİN ELBOĞA, Ahmet ÜNAL, Gökay ALPAK, Umut ELBOĞA, Mesut ÖZKAYA, Haluk SAVAŞ, FERİDUN BÜLBÜL

Electroconvulsive Therapy in A Major Depression Patient with Arachnoid Cyst

Bahadır DEMİR, İhsan AKSOY, Gökay ALPAK, Ahmet ÜNAL, Haluk SAVAŞ, FERİDUN BÜLBÜL